ATXN7L3B antibody (Cy7)
Quick Overview for ATXN7L3B antibody (Cy7) (ABIN2170449)
Target
Reactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Cross-Reactivity
- Human, Mouse, Rat
- 
                                            Purification
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic peptide derived from human ATXN7L3B
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- IF(IHC-P) 1:50-200
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- 1 μg/μL
- 
                                            Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 
                                            Preservative
- ProClin
- 
                                            Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 
                                            Expiry Date
- 12 months
 
- 
                                            
- 
    - ATXN7L3B (Ataxin 7-Like 3B (ATXN7L3B))
- 
                                            Alternative Name
- ATXN7L3B
- 
                                            Background
- 
                        Synonyms: A7L3B_HUMAN, Ataxin 7-like 3B, ATXN7L3B, Putative ataxin-7-like protein 3B. Background: ATXN7L3B 
 Target
- 
                    
 
                                     
                                     
                                    